5-hydroxytryptophan has been researched along with Supranuclear Palsy, Progressive in 2 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
Supranuclear Palsy, Progressive: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yukitake, M | 1 |
| Takashima, Y | 1 |
| Kurohara, K | 1 |
| Matsui, M | 1 |
| Kuroda, Y | 1 |
| Kompoliti, K | 1 |
| Goetz, CG | 1 |
| Litvan, I | 1 |
| Jellinger, K | 1 |
| Verny, M | 1 |
2 other studies available for 5-hydroxytryptophan and Supranuclear Palsy, Progressive
| Article | Year |
|---|---|
[Improvement of ophthalmoplegia by 5-hydroxytryptophan in two cases of progressive supranuclear palsy].
Topics: 5-Hydroxytryptophan; Aged; Female; Humans; Male; Ophthalmoplegia; Supranuclear Palsy, Progressive | 1996 |
Pharmacological therapy in progressive supranuclear palsy.
Topics: 5-Hydroxytryptophan; Aged; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Autopsy; Choliner | 1998 |